Last Updated: 31-07-2025 | Format: PDF | Report ID:20266 | Author: Ankit
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $1,050 Million |
| What is the projected market size by 2035? | $2,250 Million |
| What is the market CAGR from 2025 to 2035? | 7.9% |
| Which region dominates the market? | United States (76%) |
| Which product/service type dominates the market? | Molecular Diagnostic Tests (42%) |
| Which application leads the market? | Hospitals (38%) |
| Who are the major buyers? | Hospitals (42%), Diagnostic Laboratories (26%) |
| What are the key market growth drivers? | Rising prevalence of sexually transmitted infections (STIs) and increasing awareness about the importance of early diagnosis—Hologic; Technological advancements in molecular diagnostics |
| What are the major market challenges? | Stringent regulatory approval processes and varying reimbursement policies—Cepheid (a Danaher company) faced delays in FDA-clearances for multiplex panel upgrades in early 2025; Managing supply chain complexities for rapid and at-home testing kits—Qiagen N |
| What is the forecast period? |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| 2026–2035 |
| Who are the key market players? | Abbott Laboratories, Roche Diagnostics, Hologic, Inc., Siemens Healthineers, BioMérieux, Danaher Corporation, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Cepheid (a Danaher Company), QuidelOrtho Corporation, Gen-Probe Incorporated, Bio-Rad Laboratories, Qiagen N.V., Trinity Biotech, Luminex Corporation |
Global Vegan Beauty And Personal Care Products Market: by Type (Skincare, Haircare, Makeup, Fragrances, Bath & Shower, Others), Application (Men, Women, Children, Unisex, Elderly, Others), Distribution Channels (Supermarkets/Hypermarkets, Specialty Stores, Online Retail, Convenience Stores, Pharmacies, Others), Technology (Natural Ingredients, Synthetic-Free Formulations, Cruelty-Free Testing, Biodegradable Packaging, Plant-Based Extractions, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Residual DNA Testing Market: by Type (qPCR-based Residual DNA Testing, PCR-based Residual DNA Testing, DNA Hybridization, ELISA-based Residual DNA Testing, Others), Application (Biopharmaceuticals, Vaccines, Gene Therapy, Cell Therapy, Blood and Plasma Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Others), Technology (qPCR, PCR, Hybridization, ELISA, Capillary Electrophoresis, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
US Early Stage Cancer Market Market: by Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Other Cancers), Application (Diagnosis, Screening, Monitoring, Prognosis, Treatment Planning, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Research Institutes, Retail Pharmacies, Online Providers, Others), Technology (Imaging, Molecular Diagnostics, Genomics, Biomarker Testing, Others), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Human Identification Market Market: by Type (DNA Analysis, Biometric Analysis, Facial Recognition, Fingerprint Analysis, Iris Recognition, Voice Recognition) Application (Forensic Applications, Paternity Testing, Disaster Victim Identification, Population Genetics, Wildlife Forensics, Others), Distribution Channels (Online, Offline, Direct Sales, Distributors, Resellers, Others), Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Capillary Electrophoresis, Automated Fingerprint Identification, Digital Imaging, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Newborn Screening Market: by Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types), Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels), Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025